India’s GARP Investing Edge: Overcome Valuation Hurdles

MicroStockHub/iStock via Getty Images India is an emerging economic powerhouse, and equity valuations are near record highs. We believe GARP investing may be key to accessing its growth while navigating soaring valuations. With India on track to become the world’s third-largest economy with a projected GDP of $5T by 20271, this emerging economic powerhouse has…

Read More

Mesoblast Has Major Hurdles (NASDAQ:MESO)

DarkGel Late in November, Mesoblast (NASDAQ:MESO) filed for orphan drug designation and rare pediatric disease designation for its allogeneic cell therapy Revascor® (rexlemestrocel-L) in the treatment of the congenital heart disease hypoplastic left heart syndrome (HLHS). This is its second cell therapy program, the first being remestemcel-L targeting pediatric acute graft versus host disease (aGVHD),…

Read More